Detalles de la búsqueda
1.
Immunogenicity of Human Interferon-Beta-Containing Pharmaceuticals.
Biochemistry (Mosc)
; 81(11): 1396-1400, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914464
2.
[The methods of detection of binding and neutralizing antibodies to preparations of interferon-beta].
Klin Lab Diagn
; 61(10): 710-4, 2016 Oct.
Artículo
en Ruso
| MEDLINE | ID: mdl-30615336
3.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Mult Scler
; 21(8): 1013-24, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25680984
4.
The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
AJNR Am J Neuroradiol
; 41(5): 804-808, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32381540
5.
[Comorbidity of neuromyelitis optica spectrum disorder and systemic lupus erythematosus]. / Komorbidnost' zabolevaniya spektra optikoneiromielita i sistemnoi krasnoi volchanki.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(7): 102-108, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32790983
6.
[Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders]. / Aktual'nye voprosy diagnostiki zabolevanii spektra optikoneiromielita pri opredelenii antitel k akvaporinu-4 v syvorotke krovi.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(7. Vyp. 2): 24-31, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32844626
7.
[New directions of immunocorrection in multiple sclerosis]. / Novye napravleniia immunokorrektsii pri rasseiannom skleroze.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(2): 103-109, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32307419
8.
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)]. / Obnovlennye rekomendatsii soveta ekspertov po primeneniyu i obespecheniyu bezopasnosti terapii preparatom alemtuzumab (Lemtrada).
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(3): 82-91, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32323949
9.
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]. / Éffektivnost' i bezopasnost' siponimoda u patsientov s vtorichno-progressiruiushchim rasseiannym sklerozom v rossiiskoi populiatsii.
Zh Nevrol Psikhiatr Im S S Korsakova
; 119(10. Vyp. 2): 110-119, 2019.
Artículo
en Ruso
| MEDLINE | ID: mdl-31934996
10.
[Provision of alemtuzumab safety is one of the main components of pharmacovigilance]. / Obespechenie bezopasnosti terapii alemtuzumabom - odna iz glavnykh sostavliaiushchikh farmakonadzora.
Zh Nevrol Psikhiatr Im S S Korsakova
; 118(8. Vyp. 2): 82-87, 2018.
Artículo
en Ruso
| MEDLINE | ID: mdl-30160673
11.
Improvement of gait and balance in patients with multiple sclerosis after multidisciplinary physical rehabilitation: Analysis of real-world data in Russia.
Mult Scler Relat Disord
; 59: 103640, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131727
12.
[The association of intrathecal production of immunoglobulin free light chains and progression of multiple sclerosis]. / Sviaz' intratekal'noi produktsii svobodnykh legkikh tsepei immunoglobulinov s progressirovaniem rasseiannogo skleroza.
Zh Nevrol Psikhiatr Im S S Korsakova
; 117(10. Vyp. 2): 4-10, 2017.
Artículo
en Ruso
| MEDLINE | ID: mdl-29359727
13.
[Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis]. / Rol' opredeleniia svobodnykh legkikh tsepei immunoglobulinov v diagnostike debiuta rasseiannogo skleroza.
Zh Nevrol Psikhiatr Im S S Korsakova
; 117(2. Vyp. 2): 60-65, 2017.
Artículo
en Ruso
| MEDLINE | ID: mdl-28617363
14.
[Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis]. / Sovremennye predstavleniya ob intratekal'nom gumoral'nom immunnom otvete i diagnosticheskoe znachenie vyyavleniya oligoklonal'nykh immunoglobulinov pri rasseyannom skleroze.
Zh Nevrol Psikhiatr Im S S Korsakova
; 116(2 Pt 2): 14-20, 2016.
Artículo
en Ruso
| MEDLINE | ID: mdl-27070356
15.
[A prospective, open, non-randomized study on the safety and efficacy of natalizumab (tisabri) in the Russian population of patients with relapsing-remitting multiple sclerosis]. / Prospektivnoe otkrytoe nerandomizirovannoe klinicheskoe issledovanie bezopasnosti i éffektivnosti terapii natalizumabom (tizabri) v rossiiskoi populiatsii patsientov s retsidiviruiushche-remittiruiushchim rasseiannym sklerozom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 115(8. Vyp. 2): 25-35, 2015.
Artículo
en Ruso
| MEDLINE | ID: mdl-28635712
16.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation].
Zh Nevrol Psikhiatr Im S S Korsakova
; 114(8): 39-45, 2014.
Artículo
en Ruso
| MEDLINE | ID: mdl-25345629
17.
[Symptomatic epilepsy in inflammatory demyelinating diseases].
Zh Nevrol Psikhiatr Im S S Korsakova
; 111(2 Pt 2): 38-51, 2011.
Artículo
en Ruso
| MEDLINE | ID: mdl-21916156
18.
[Recommendations on the algorithms for drug choice and risk management plan in the treatment of patients with remitting multiple sclerosis with natalizumab]. / Rekomendatsii po algoritmu vybora preparata i planu upravleniya riskami terapii natalizumabom u patsientov s remittiruyushchim rasseyannym sklerozom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 116(10 Pt 2): 79-97, 2016.
Artículo
en Ruso
| MEDLINE | ID: mdl-28139616
Resultados
1 -
18
de 18
1
Próxima >
>>